Autopsy report · NCT01176812

Dermal Fillers Patient Satisfaction

“Difficult to recruit subjects in the area.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Wake Forest University

Sponsor type

University, hospital or other

Conditions

Loss of Facial Fat

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children
  “inability to recruit subjects” (83% match in meaning)
• Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy
  “Due to difficulties in recruiting the subjects.” (82% match in meaning)
• Exercise Therapy for Asthma (ETA Trial)
  “Study proved difficult to recruit” (77% match in meaning)
• The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
  “Inability to recruit eligible subjects” (77% match in meaning)
• Sputum-derived Cellular Targets After Xolair (Omalizumab)
  “Difficulty recruiting subjects” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.